Peter Francis
Director/Board Member bei BENITEC BIOPHARMA INC.
Vermögen: 1 559 $ am 31.03.2024
Profil
Peter Francis is currently an Independent Non-Executive Director at Benitec Biopharma Ltd., a Non-Executive Director at Optiscan Pty Ltd., and an Independent Non-Executive Director at Benitec Biopharma, Inc. He previously worked as a Partner at FAL Lawyers.
Mr. Francis has also held former positions as an Executive Director at Cryosite Ltd., a Non-Executive Director at Optiscan Imaging Ltd., Xceed Capital Ltd., Rision Ltd., and the International Society of Differentiation, Inc. He has also served as an Executive Director at Bioxyne Ltd., BCAL Diagnostics Ltd., and AusDiagnostics Pty Ltd., as well as a Director at Neuroscope Ltd.
Mr. Francis's education includes a graduate degree from Monash University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BENITEC BIOPHARMA INC
0,01% | 06.12.2023 | 297 ( 0,01% ) | 1 559 $ | 31.03.2024 |
Aktive Positionen von Peter Francis
| Unternehmen | Position | Beginn |
|---|---|---|
| BENITEC BIOPHARMA INC. | Director/Board Member | 01.10.2017 |
Benitec Biopharma Ltd.
 Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Director/Board Member | 12.10.2017 |
| FAL Lawyers | Corporate Officer/Principal | 01.01.1993 |
Optiscan Pty Ltd.
 Optiscan Pty Ltd. Medical SpecialtiesHealth Technology Optiscan Pty Ltd. develops microscopic imaging technologies for medical markets. The company was founded in 1994 and is headquartered in Melbourne, Australia. | Director/Board Member | - |
Ehemalige bekannte Positionen von Peter Francis
| Unternehmen | Position | Ende |
|---|---|---|
| OPTISCAN IMAGING LIMITED | Director/Board Member | 23.04.2018 |
| RISION LIMITED | Director/Board Member | 12.04.2018 |
Xceed Capital Ltd.
 Xceed Capital Ltd. Chemicals: Major DiversifiedProcess Industries Xceed Capital Ltd. is engaged in the manufacture of pharmaceutical products. The company's business includes chemical segment which is a supplier of organo-boron compounds. Xceed Capital is headquartered in Perth, Australia. | Director/Board Member | 16.12.2008 |
| CRYOSITE LIMITED | Director/Board Member | - |
| BCAL DIAGNOSTICS LIMITED | Director/Board Member | - |
Ausbildung von Peter Francis
| Monash University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| CRYOSITE LIMITED | Commercial Services |
| OPTISCAN IMAGING LIMITED | Health Technology |
| BIOXYNE LIMITED | Commercial Services |
| BCAL DIAGNOSTICS LIMITED | Health Services |
| INOVIQ LTD | Health Services |
| BENITEC BIOPHARMA INC. | Health Technology |
| Private Unternehmen | 8 |
|---|---|
Xceed Capital Ltd.
Xceed Capital Ltd. Chemicals: Major DiversifiedProcess Industries Xceed Capital Ltd. is engaged in the manufacture of pharmaceutical products. The company's business includes chemical segment which is a supplier of organo-boron compounds. Xceed Capital is headquartered in Perth, Australia. | Process Industries |
Benitec Biopharma Ltd.
Benitec Biopharma Ltd. BiotechnologyHealth Technology Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in Melbourne, Australia. | Health Technology |
Rision Ltd.
 Rision Ltd. Packaged SoftwareTechnology Services Rision Ltd. is engages in rubber recycling and manufacturing to convert used rubber tires into surfacing, molded and granule products for a wide range of industries in both domestic and international markets. The company was founded by Robert John Day on November 24, 1999 and is headquartered in Perth, Australia. | Technology Services |
Optiscan Pty Ltd.
Optiscan Pty Ltd. Medical SpecialtiesHealth Technology Optiscan Pty Ltd. develops microscopic imaging technologies for medical markets. The company was founded in 1994 and is headquartered in Melbourne, Australia. | Health Technology |
International Society of Differentiation, Inc.
 International Society of Differentiation, Inc. Miscellaneous Commercial ServicesCommercial Services International Society of Differentiation, Inc. engages in development, research and communication in the fields of cell and developmental biology, molecular biology and oncology. The company was founded by Jean Louis Auguste Brachet in 1971 and is headquartered in St. Paul, MN. | Commercial Services |
| FAL Lawyers | |
| Neuroscope Ltd. | |
AusDiagnostics Pty Ltd.
 AusDiagnostics Pty Ltd. Medical SpecialtiesHealth Technology Part of RMD Holding GmbH, AusDiagnostics Pty Ltd. is a manufacturer and supplier of molecular diagnostics products and reagents. The private company is based in Mascot, Australia. The Australian company was founded in 2006 by Keith Stanley. Scott Gilroy has been the CEO of the company since 2020. AusDiagnostics was acquired by R-Biopharm AG on June 07, 2022. | Health Technology |
